Recursion Pharmaceuticals (RXRX) Stock Highlights

5.7 | -0.87%

2024-11-23 03:03:39

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Statistics

Range Today

5.6 5.99

Volume Today 13.67M

Range 1 Year

5.62 15.74

Volume 1 Year 1.45B

Range 3 Year

4.54 21.19

Volume 3 Year 2.55B

Range 10 Year

4.54 42.81

Volume 10 Year 2.65B

Highlights

Market Capitalization 1.99B (small)

Floating Shares 247.85M

Current Price 5.7

Price To Earnings -4.34

Price To Revenue 25.61

Price To Book 3.83

Earnings Per Share -1.58

Payout Ratio 0%

Performance

Latest -0.87%

1 Month -14.93%

3 Months -25.97%

6 Months -40.13%

1 Year -14.8%

3 Years -70.69%

5 Years -81%

10 Years -81%

Benchmarks

Market Capitalization

54 / 368

Gross Profits

258 / 278

Total Revenue

127 / 300

Total Rank

244 / 368

Free Cashflow

306 / 352

Performance 5 years

236 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.